This site is intended for healthcare professionals
Guidelines
  • Home
  • /
  • Guidelines
  • /
  • Venous Thromboembolism
  • /
  • BSH Guideline: management of thrombotic and haemos...
Guideline

BSH Guideline: management of thrombotic and haemostatic issues in paediatric malignancy

Read time: 1 mins
Last updated:30th Jan 2018
BSH Guideline: management of thrombotic and haemostatic issues in paediatric malignancy - British Society for Haematology (BSH)


Venous thromboembolism (VTE) and bleeding are serious complications of cancer and its treatment. A recent survey of UK paediatric haematologists and oncologists identified a broad variety of practice in the management of issues relating to these complications in children with leukaemia, reflecting significant areas of uncertainty (Biss et al, 2016a, 2017). The purpose of this guideline is to provide information and guidance on the management of these issues in children being treated for leukaemia and other forms of cancer.

The following areas are covered:
• Assessment and reduction of the risk of VTE
• Treatment of the various types of VTE
• Management of thrombocytopenia and coagulopathy
• Therapy for menstrual suppression

 

Read full guideline